Rein Piir was born on 1958. He is Vice President Investor Relations since 2016. He is a Swedish graduate in business administration from Uppsala University and has many years of experience of providing consultancy services to stock market companies, including as a strategist at Alecta and head of analysis at Carnegie Investment Bank AB. Other experience includes CFO/Head of Investor Relations at Medivir AB and accountant at PricewaterhouseCoopers AB. Rein Piir currently also holds the position of VP Investor Relations at Camurus AB and Oncopeptides AB. Member of the Management Team since 2016. He is also Chairman and CEO of Piir & Partner AB.Board member of Integrative Research Laboratories Sweden AB, L. E. Svensson Snickeri Aktiebolag and Trygga Pengar i Mobilen Sverige AB.
Haematology